Licensed Products
Licensed Products Current Research Management Contact Home	Polyphenon® E for the treatment of HPV infections Mitsui Norin Company, Japan / MediGene AG, Germany In 1997 Epitome Pharmaceuticals Ltd. licensed from Mitsui Norin Company (Japan), a patented method of treating external genital warts through the topical application of Polyphenon® E green tea extract. Within two years, Epitome sublicensed this technology to MediGene AG, a publicly traded German biotech company. MediGene and Epitome collaborated on a multi-centre Phase II trial. In October 2006 the US FDA approved Veregen™, the first botanical approved under new regulations. more —> Topical Therapy for the treatment of chronic pain Dalhousie University, Canada / EpiCept Corporation, U.S.A. In 1999 Epitome Pharmaceuticals Ltd. licensed from Dalhousie University (Canada) a patented method for treating neuropathic pain through the topical application of a formulation containing ketamine and amitriptylline. Shortly thereafter we licensed this technology on to EpiCept Corporation of Englewood Cliffs, New Jersey. more —>
	Polyphenon® is a registered trademark of Mitsui Norin Co., Ltd.